de Northern Trust Utah Medical Products UTMD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 2.08 M | Vender |
30,104
-188
| -0.6% | -USD 12.5 k | ﹤0.01% | 3117 |
|
|
2026
Q1 | USD 1.88 M | Comprar |
30,292
+1,015
| +3% | +USD 63.9 k | ﹤0.01% | 3009 |
|
|
2025
Q4 | USD 1.64 M | Vender |
29,277
-2,120
| -7% | -USD 123 k | ﹤0.01% | 3111 |
|
|
2025
Q3 | USD 1.98 M | Vender |
31,397
-2,043
| -6% | -USD 121 k | ﹤0.01% | 3045 |
|
|
2025
Q2 | USD 1.9 M | Vender |
33,440
-732
| -2% | -USD 39.8 k | ﹤0.01% | 3014 |
|
|
2025
Q1 | USD 1.91 M | Vender |
34,172
-2,660
| -7% | -USD 159 k | ﹤0.01% | 2946 |
|
|
2024
Q4 | USD 2.26 M | Comprar |
36,832
+1,773
| +5% | +USD 115 k | ﹤0.01% | 2957 |
|
|
2024
Q3 | USD 2.35 M | Vender |
35,059
-713
| -2% | -USD 48.4 k | ﹤0.01% | 2902 |
|
|
2024
Q2 | USD 2.39 M | Vender |
35,772
-1,288
| -3% | -USD 87.7 k | ﹤0.01% | 2805 |
|
|
2024
Q1 | USD 2.64 M | Vender |
37,060
-1,528
| -4% | -USD 115 k | ﹤0.01% | 2822 |
|
|
2023
Q4 | USD 3.25 M | Comprar |
38,588
+1,422
| +4% | +USD 118 k | ﹤0.01% | 2721 |
|
|
2023
Q3 | USD 3.2 M | Vender |
37,166
-11
| -0% | -USD 1.02 k | ﹤0.01% | 2684 |
|
|
2023
Q2 | USD 3.46 M | Vender |
37,177
-669
| -2% | -USD 63 k | ﹤0.01% | 2704 |
|
|
2023
Q1 | USD 3.59 M | Comprar |
37,846
+152
| +0.4% | +USD 14 k | ﹤0.01% | 2652 |
|
|
2022
Q4 | USD 3.79 M | Comprar |
37,694
+601
| +2% | +USD 54.9 k | ﹤0.01% | 2654 |
|
|
2022
Q3 | USD 3.16 M | Vender |
37,093
-141
| -0.4% | -USD 12.4 k | ﹤0.01% | 2760 |
|
|
2022
Q2 | USD 3.2 M | Comprar |
37,234
+194
| +0.5% | +USD 16.5 k | ﹤0.01% | 2802 |
|
|
2022
Q1 | USD 3.33 M | Vender |
37,040
-1,360
| -4% | -USD 125 k | ﹤0.01% | 2823 |
|
|
2021
Q4 | USD 3.84 M | Vender |
38,400
-526
| -1% | -USD 53.7 k | ﹤0.01% | 2855 |
|
|
2021
Q3 | USD 3.61 M | Vender |
38,926
-1,609
| -4% | -USD 142 k | ﹤0.01% | 2942 |
|
|
2021
Q2 | USD 3.45 M | Vender |
40,535
-2,611
| -6% | -USD 226 k | ﹤0.01% | 3060 |
|
|
2021
Q1 | USD 3.74 M | Vender |
43,146
-8,245
| -16% | -USD 725 k | ﹤0.01% | 2922 |
|
|
2020
Q4 | USD 4.33 M | Vender |
51,391
-3,696
| -7% | -USD 315 k | ﹤0.01% | 2764 |
|
|
2020
Q3 | USD 4.4 M | Vender |
55,087
-1,996
| -3% | -USD 166 k | ﹤0.01% | 2623 |
|
|
2020
Q2 | USD 5.06 M | Vender |
57,083
-300
| -0.5% | -USD 26.9 k | ﹤0.01% | 2512 |
|
|
2020
Q1 | USD 5.4 M | Comprar |
57,383
+1,192
| +2% | +USD 111 k | ﹤0.01% | 2263 |
|
|
2019
Q4 | USD 6.06 M | Vender |
56,191
-875
| -2% | -USD 88.7 k | ﹤0.01% | 2475 |
|
|
2019
Q3 | USD 5.47 M | Comprar |
57,066
+2,686
| +5% | +USD 250 k | ﹤0.01% | 2499 |
|
|
2019
Q2 | USD 5.2 M | Vender |
54,380
-719
| -1% | -USD 60.5 k | ﹤0.01% | 2538 |
|
|
2019
Q1 | USD 4.86 M | Comprar |
55,099
+251
| +0.5% | +USD 22.1 k | ﹤0.01% | 2583 |
|
|
2018
Q4 | USD 4.56 M | Vender |
54,848
-1,807
| -3% | -USD 159 k | ﹤0.01% | 2561 |
|
|
2018
Q3 | USD 5.34 M | Comprar |
56,655
+1,249
| +2% | +USD 119 k | ﹤0.01% | 2652 |
|
|
2018
Q2 | USD 6.1 M | Comprar |
55,406
+2,158
| +4% | +USD 225 k | ﹤0.01% | 2582 |
|
|
2018
Q1 | USD 5.26 M | Comprar |
53,248
+388
| +0.7% | +USD 34.6 k | ﹤0.01% | 2551 |
|
|
2017
Q4 | USD 4.3 M | Comprar |
52,860
+148
| +0.3% | +USD 11.6 k | ﹤0.01% | 2698 |
|
|
2017
Q3 | USD 3.88 M | Vender |
52,712
-582
| -1% | -USD 41.9 k | ﹤0.01% | 2793 |
|
|
2017
Q2 | USD 3.86 M | Comprar |
53,294
+305
| +0.6% | +USD 20.1 k | ﹤0.01% | 2774 |
|
|
2017
Q1 | USD 3.3 M | Comprar |
52,989
+916
| +2% | +USD 57.7 k | ﹤0.01% | 2807 |
|
|
2016
Q4 | USD 3.79 M | Comprar |
52,073
+761
| +1% | +USD 49.5 k | ﹤0.01% | 2729 |
|
|
2016
Q3 | USD 3.07 M | Comprar |
51,312
+1,103
| +2% | +USD 70.2 k | ﹤0.01% | 2829 |
|
|
2016
Q2 | USD 3.16 M | Vender |
50,209
-2,489
| -5% | -USD 161 k | ﹤0.01% | 2766 |
|
|
2016
Q1 | USD 3.3 M | Comprar |
52,698
+905
| +2% | +USD 53.4 k | ﹤0.01% | 2682 |
|
|
2015
Q4 | USD 3.03 M | Vender |
51,793
-48
| -0.1% | -USD 2.72 k | ﹤0.01% | 2791 |
|
|
2015
Q3 | USD 2.79 M | Comprar |
51,841
+515
| +1% | +USD 28.1 k | ﹤0.01% | 2834 |
|
|
2015
Q2 | USD 3.06 M | Vender |
51,326
-1,353
| -3% | -USD 76.2 k | ﹤0.01% | 2829 |
|
|
2015
Q1 | USD 3.15 M | Vender |
52,679
-1,934
| -4% | -USD 114 k | ﹤0.01% | 2813 |
|
|
2014
Q4 | USD 3.28 M | Comprar |
54,613
+189
| +0.3% | +USD 10.5 k | ﹤0.01% | 2773 |
|
|
2014
Q3 | USD 2.65 M | Comprar |
54,424
+4,068
| +8% | +USD 207 k | ﹤0.01% | 2910 |
|
|
2014
Q2 | USD 2.59 M | Vender |
50,356
-5,507
| -10% | -USD 283 k | ﹤0.01% | 2926 |
|
|
2014
Q1 | USD 3.23 M | Vender |
55,863
-2,535
| -4% | -USD 138 k | ﹤0.01% | 2838 |
|
|
2013
Q4 | USD 3.34 M | Comprar |
58,398
+590
| +1% | +USD 32.4 k | ﹤0.01% | 2835 |
|
|
2013
Q3 | USD 3.44 M | Vender |
57,808
-2,855
| -5% | -USD 156 k | ﹤0.01% | 2751 |
|
|
2013
Q2 | USD 3.29 M | Comprar |
+60,663
| Nuevas | +USD 2.86 M | ﹤0.01% | 2678 |
|
Otros fondos que tienen UTMD en su cartera
MA
Posición de Northern Trust en UTMD: resumen de T2 2026
Northern Trust redujo su participación en Utah Medical Products (UTMD) en 0.62% durante T2 2026, al vender acciones por un valor estimado de USD 12.5 k, y conservó 30,104 acciones valuadas en USD 2.08 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #3117.
Northern Trust reportó por primera vez una posición en UTMD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 6.1 M en T2 2018. Al cierre de T2 2026, 114 fondos que sigue Wall St. Rank mantienen una posición en UTMD.
- Al cierre de T2 2026, Northern Trust tenía 30,104 acciones de Utah Medical Products con un valor de USD 2.08 M.
- Northern Trust vendió 188 acciones de Utah Medical Products en T2 2026, por un valor estimado de USD 12.5 k.
- Utah Medical Products representó ﹤0.01% de la cartera de Northern Trust en T2 2026 y fue su posición número 3117.
- Northern Trust reportó por primera vez una posición en Utah Medical Products en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Northern Trust en Utah Medical Products alcanzó su máximo de USD 6.1 M en T2 2018.
- Al cierre de T2 2026, 114 fondos que sigue Wall St. Rank tenían Utah Medical Products en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.